Skip to main content

Table 1 Patient, tumor, and treatment characteristics, and association with radiation-induced lung injury

From: Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy

Characteristic No. of patients (%) p value
Gender   0.380
Male: Female 48 (84.2): 9 (15.8)  
Age (y)   0.750
≥ 60: < 60 36 (63.2): 21 (36.8)  
Karnofsky Performance Status   0.470
80: >80 13 (22.8): 44 (77.2)  
Histopathology   -
Squamous cell carcinoma 28 (49.1)  
Adenocarcinoma 20 (35.1)  
Large cell carcinoma 3 (5.3)  
NSCLC, not otherwise specified 6 (10.5)  
Clinical stage   1.000
IIIA: IIIB 19 (33.3): 38 (66.7)  
Smoking history   0.702
No: Yes 12 (21.1): 45 (78.9)  
Chemotherapy   0.301
Concurrent: Sequential 17 (29.8): 40 (70.2)  
Primary tumor location   0.087
Upper: Middle and lower lobe 25 (43.9): 32 (56.1)